{"title": "Merck's chronic cough med gets a nay from FDA, potentially clearing first-to-market path for Bellus", "author": "Kyle LaHucik", "url": "https://www.fiercebiotech.com/biotech/merck-s-chronic-cough-med-rejected-by-fda-accepted-japan-potentially-paving-way-for-bellus", "hostname": "fiercebiotech.com", "description": "The FDA rejected Merck's chronic cough treatmen | The FDA rejected Merck's chronic cough treatment, potentially setting up more breathing room for competitor Bellus Health in a first-to-market battle.", "sitename": "FierceBiotech", "date": "2022-01-24", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}